verified SJR 3,057 · Q1 • database Scopus / SJR & Web of Science indexed

United Kingdom · Oxford University Press

workspace_premium Q1 — Physiology (medical) lock_open Open Access

Europace

Europace is a journal indexed in SJR in Physiology (medical) and Cardiology and Cardiovascular Medicine with an H index of 137. It has an SJR impact factor of 3,057 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 3,057.

Europace focuses its scope in these topics and keywords: atrial, fibrillation, pulmonary, isolation, multicentre, cardiac, study, ablation, heart, effect, ...

ISSN: 1099-5129

Publisher: Oxford University Press

Category: Physiology (medical)

Indexation: verifiedScopus / SJR verifiedWeb of Science

open_in_new Portal NPD menu_book Guidelines NPD

schedule CountryOfPapers database fields

SJR Impact Factor trending_up

3,057 Q1

H-index 137

Acceptance rate pie_chart

24% Selective

Source Acceptance_Rate

Time to publication hourglass_top

NPD

Field NPD

Publication cost (APC) payments

NPD Open Access

Non-OA path 0 €

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR Web of Science

SJR Impact

3,057

H-index

137

Docs (year)

313

Docs 3y

1121

Total refs

11178

Cites 3y

5836

Citable 3y

856

Cites/Doc 2y

5.52

Ref/Doc

35.71

Immediate OA

—

Embargoed OA

NPD

Non OA / Submission

0 €

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims

rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID * * Only to validate authenticity — identity is not shown publicly.

Best articles by citations

A02-5 Endothelial damage and activation of the hemostatic system during radiofrequency catheter isolation of pulmonary veins

The DATAS rationale and design: a controlled, randomized trial to assess the clinical benefit of dual chamber (DDED) defibrillator

A04-5 Autonomic function in patients with defaecation syncope

A04-4 Cough syncope: An uncommon but important cause of syncope

A04-3 Prevalence of postural orthostatic tachycardia syndrome in patients with unexplained syncope. Clinical presentation and tilt test results

A04-2 Cardiovascular autonomic regulations in patients with recurrent vasovagal syncope and positive head-upright tilt table test

A04-1 Myocardial adrenergic innervation in patients with unexplained syncope

A03-6 Upgrading from rv pacing to biventricular pacing in previously paced patients with advanced heart failure: A randomized controlled study

A03-5 Cardiac resynchronisation therapy allows medical therapy optimization in patients with advanced congestive heart failure? Results of the insync/insyncicd Italian registries

A03-3 Prediction of clinical response to cardiac resynchronization therapy by QRS duration and shortening

A03-2 Cost-effectiveness analysis of biventricular pacing

A03-1 Long-term clinical outcome and device performance of biventricular pacing: A single center evaluation from three-year follow-up of consecutive heart failure patients

SHOW MORE ARTICLES

A02-6 New automatic diagnostic functions for quantification of atrial arrhythmias in pacemaker patients

42Atrial fibrillation ablation as a day-case procedure: three-year single-centre experience

A02-4 Incidence of cerebral embolism in patients with atrial fibrillation and cardioversion

A02-3 Conversion of atrial fibrillationto sinus rhythm could induce hyperclotting state: The relationship with the atrial fibrillation duration

A02-2 Atrial fibrillation and thrombus formation: Time depended or genetic disorders?

A02-1 Incidence of cerebral embolism in high risk patients with atrial fibrillation

A01-6 The application of a programme of home-based tilt ? trainig in patients suffering from vasovagal syncope

A01-5 Long-term follow-up in patients with vasovagal syncope

A01-4 Response to head-up tilt testing and follow-up in patients with situational syncope; Comparison with vasovagal syncope

A01-3 The effect of beta-blockers on the central serotonergic responsivity, in patients with neurocardiogenic syncope

A01-2 Detecting baroreflex activity by a sequential analysis during head-up tilt test in young women with syncope

A01-1 Adenosine-induced syncope: Prevalence and characteristics

FAQs

Europace has an SJR of 3,057 (best quartile Q1) in the CountryOfPapers database.

Immediate OA APC is not available (NPD). Non-OA / submission fee is 0 EUR.

The acceptance rate recorded for Europace is 24%.

Europace

Metrics

Name good journals. Call out predatory ones.

Researcher reviews

Best articles by citations

FAQs

What is the SJR of Europace?

What is the APC / publication cost?

What is the acceptance rate?